Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sharps Technology, Inc. ( (STSS) ) has issued an update.
Sharps Technology, Inc. has struck significant sales agreements with a major European healthcare network to deliver its SecureGard safety syringes, marking a pivotal expansion in Central and Eastern Europe. The company plans to fulfill all current inventory demands by early 2025 and aims to boost its manufacturing capacity to meet rising demand for its innovative syringe solutions. This move positions Sharps to capitalize on the growing demand for injectable therapies while enhancing their manufacturing capabilities in Hungary.
Find detailed analytics on STSS stock on TipRanks’ Stock Analysis page.
Trending Articles
- Oppenheimer Pounds the Table on Coinbase Stock
- New “Anti-Woke” ETF Targets Starbucks (NASDAQ:SBUX)
- Ford (NYSE:F) Plans New EV Plant
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.